• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Emerging Technology Market
    Emerging Technology News
    Emerging Technology Stocks
    • Emerging Technology Market
    • Emerging Technology News
    • Emerging Technology Stocks
    3d printing investing

    Modelife Announces Collaboration with Exactech Australia

    Written by Morag Mcgreevey
    |
    Nov. 23, 2015 02:18PM PST

    Modelife, a Materialise (NASDAQ:MTLS) company, has joined in a collaboration with Exactech Australia. This is intended to bring Modelife’s portfolio of custom implants to the Australian market.

    Modelife, a Materialise (NASDAQ:MTLS) company, has joined in a collaboration with Exactech Australia. This is intended to bring Modelife’s portfolio of custom implants to the Australian market.
    According to the press release:

    As the exclusive independent distributor of Exactech Inc. in the Australian market, Exactech Australia is dedicated to providing innovative products and intuitive instrumentation as well as delivering on Exactech’s promise of being “Surgeon focused, patient driven”. Through their partnership with Mobelife, Exactech Australia will be able to expand their innovative portfolio of hip and shoulder solutions to specialist surgeons in Australia. Of key importance to Mobelife is that this partnership will maintain the close and dynamic collaboration between the surgeon and Mobelife’s expert team, a key aspect in the design process of both aMace and Glenius hip and shoulder implants, which is completely personalized to both the patient and surgeon.
    Tim Clijmans, co-founder and CEO of Mobelife and Director of Global Clinical Direct Sales at Materialise, states, “Mobelife is proud to offer all-in-one unique solutions matching the patient’s anatomy and pathology as well as the surgeon’s needs in many countries, so it is exciting to now be bringing our full portfolio to Australian surgeons and their patients with Exactech Australia. Given Exactech’s leadership in upper-extremities, it is especially exciting to collaborate with its distributor to bring our novel shoulder reconstruction solution to the region.”

    Click here to read the full press release.


     
    australia3d printing investing
    The Conversation (0)

    Go Deeper

    AI Powered
    agriculture stocks

    Earth Alive Announces US$180,000 Soil Activator Sale to New Customer in California

    Nextech3D.ai Achieves Milestone with 3D AI Modeling Profit Margins Hitting 80% in Q2 2024 Up From 30% in 2023

    Nextech3D.ai Achieves Milestone with 3D AI Modeling Profit Margins Hitting 80% in Q2 2024 Up From 30% in 2023

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Emerging Technology Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES